Literature DB >> 31402605

Efficacy of a Modified Scoring System to Facilitate Surgical Decision-making for Diaphyseal Malignancies: When is Devitalized Tumor-bearing Autograft of Value?

Yu Chen1, Xiu-Chun Yu2.   

Abstract

OBJECTIVES: To evaluate the validity of a modified scoring system (MSS) for inferring the bony quality of tumor-bearing diaphyses and predicting the risk of reconstructive failure after devitalized bone replantation (DBR).
METHODS: In this retrospective cohort study, we reviewed the records of 30 patients surgically treated for diaphyseal malignancies between 1996 and 2015. There were 18 male and 12 female subjects; the average age was 34.0 ± 24.5 years (8-82 years). Tumor locations comprised the femur (21), the humerus (4), the tibia (3), the radius (1), and the fibula (1). Histological diagnoses included osteosarcoma (13), metastases (4), Ewing sarcoma (3), chondrosarcoma (3), malignant fibrohistiocytoma (2), periosteal osteosarcoma (1), Langerhans cell sarcoma (1), lymphoma (1), rhabdomyosarcoma (1), and malignant giant cell tumor (1). All primary tumors were rated as stage IIB. Twenty patients underwent DBR. Prosthetic procedures and segmental autografting/allografting were performed in 7 and 3 cases, respectively. MSS (comprising 5 elements: pain, tumor location, bone destruction, localized dimension, and longitudinal dimension) for each patient was calculated in accordance with their preoperative presentations. Outcome measurements included oncological results, outcomes of reconstructions, complications, and functional preservation, presented using the musculoskeletal tumor society (MSTS) scale.
RESULTS: Follow up was available in 29 cases for an average duration of 61.0 ± 49.9 months (12-152 months). Infection occurred in 2 patients (6.9%), primary nonunion in 6 (27.3%), metastases in 9 (31.9%), recurrences in 4 (13.8%), and deaths in 7 (24.1%); 1 subject underwent amputation due to recurrence following endoprosthetic replacement (3.4%). In the DBR group, fractures occurred in 4 cases (21.1%) and nonunion in 5 (25%); internal fixation was related to nonunion (nails, 44.4% vs plates, 9.1%, P = 0.02). MSS was associated with fractures of devitalized autografts (11.0 ± 1.2 vs 8.3 ± 1.8, P = 0.01); the system was efficacious in predicting chances of fractures of these grafts (P = 0.02). MSS ≥ 10 (with false positive rate ≤ 6.7%) suggested increased fracture probability (≥22.7%) after DBR; therefore, 10 was considered a cutoff value.
CONCLUSIONS: Diaphyseal malignancies with MSS ≥10 may contraindicate DBR for increased chances of reconstructive failure. In this situation, alternative procedures are advisable. Further investigations are warranted to assess the efficacy of MSS in implying the validity of DBR for diaphyseal malignancies.
© 2019 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Bone neoplasms; Diaphyses; Limb salvage; Reconstructive surgical procedures

Mesh:

Year:  2019        PMID: 31402605      PMCID: PMC6712409          DOI: 10.1111/os.12502

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


Introduction

Advances in neo‐chemotherapy, chemotherapy, and surgical techniques have made limb‐salvaging surgery (LSS) the mainstay treatment of ≥80% of limb malignancies1. Previous literature has advocated various procedures, including devitalized bone replantation (DBR), autografting, allografting, distraction osteogenesis, and endoprosthetic replacement2, 3, 4, 5, 6, 7, 8, 9, 10. Rose et al. performed vascularized free‐fibula transfer for reconstruction of the humerus; the outcomes suggested that this procedure provides excellent autograft incorporation irrespective of prolonged healing time4. Benevenia et al. describe the usage of a modular intercalary endoprosthesis as treatment for segmental defects in limbs. At short‐term follow up, the implant yielded satisfactory efficacy in terms of oncological and functional results, and the authors recommended cemented fixation for immediate return to weight bearing and improved functional preservation8. However, controversy remains regarding the optimal treatment modality. Endoprosthetic procedures are associated with high revision rates (70%) and a lifelong risk of infection (12%), whereas biological reconstructions might be susceptible to complications, including infection, nonunion, fracture and absorption, occurring in up to 43% of cases2, 8, 9, 10. To date, there has not been a consensus on indications for these limb salvage procedures. A variety of factors, including age, tumor site, tumor size, soft tissue coverage, expected functional preservation, oncological prognosis and surgeons’ preference, may exert impacts on the final selection of surgical procedures2, 3, 4, 5, 6, 7, 8, 9, 10. Reconstruction using devitalized tumor‐bearing bone (including irradiation, heat ablation, liquid nitrogen, and ethanol) is a valuable procedure. The graft is easy to access, offers perfect anatomic fit, and may allow long‐term use if bone union occurs. However, fracture (17%), infection (10%) and nonunion (10%–27%) constitute major complications of this procedure and may impede the usage of this technique11, 12, 13, 14. Wu et al. reviewed the effectiveness of irradiation‐devitalized and autoclaving‐devitalized autografts as limb preservation procedures. The complication rate, including infection, fracture and nonunion, was 11%, and was higher than that for prosthetic procedures15. Pan et al. followed up outcomes of 10 re‐implanted autoclaved grafts for a mean duration of 35 months; 20% of the patients had reconstructive failure16. There are two major reasons for high complication rates reported by some authors. First, all methods of tumor sterilization may further deteriorate the skeletal quality of tumor‐bearing grafts; this could either affect the mechanical strength of the graft or slow bone incorporation. Clinical observations showed that stress fractures may even occur after bone healing is evident11, 12, 13, 14. Second, indications for DBR are unclear in most studies. If bony structure compromise of the tumor graft is too severe, the graft may not be feasible for replantation due to high risk of fractures and remote osteosynthesis. Tumor locations also warrant consideration during surgical planning. Although diaphyseal malignancies account for <10% of bone tumors, they are usually larger than metaphyseal lesions and predispose to fractures (29% vs 8%); this implies that the mechanical property of diaphyses may be distinguished from that of periarticular sites1, 2, 17. Iwata et al. conducted a case‐control study on clinical features of diaphyseal and metaphyseal osteosarcoma. The authors argued that patients with diaphyseal osteosarcomas had a significantly larger tumor (13.5 cm vs 10 cm) and demonstrated higher pathologic fracture rates (28% vs 12%)17. Therefore, evaluating the quality of tumor‐bearing diaphyses is crucial before implementing DBR; however, to our knowledge, there are no established standards determining what degrees of skeletal destruction may favor or contraindicate DBR18, 19. Mirels proposed a scoring system to reflect the bony quality and to predict fracture likelihood of diaphyseal metastases. The system includes pain, location, tumor lesion, and cortical destruction; scores ≥9 indicate fracture likelihood ≥33% and the need for prophylactic procedures19. Nevertheless, this system only addresses localized lesions without considering longitudinally extensive neoplasms, which are common among diaphyseal malignancies. It is also unknown whether a system indicating the quality of tumor bones could predict reconstructive failures of DBR2. The purposes of the present study include: (i) to adapt the scoring system depicted by Mirels to diaphyseal malignancies to better demonstrate the clinical features of tumors arising from this location; (ii) to describe the outcomes and effectiveness of various limb salvage procedures for diaphyseal malignancies at mid‐term follow up; and (iii) to analyze the effectiveness of the modified scoring system (MSS) in predicting chances of fractures of replanted devitalized autografts in the diaphyses, thereby providing deeper insights into selection of reconstructive procedures for diaphyseal malignancies.

Patients and Methods

Clinical Data

In this retrospective cohort study, we reviewed the records of 30 patients with diaphyseal malignancies treated in our institute from December 1996 to December 2015. There were 18 male subjects. The average age was 34.0 ± 24.5 years (range, 8–82 years). Tumor locations included the femur (21), the humerus (4), the tibia (3), the radius (1), and the fibula (1). Diagnoses were osteosarcoma (13), metastases (4), Ewing sarcoma (3), chondrosarcoma (3), malignant fibrohistiocytoma (2), periosteal osteosarcoma (1), Langerhans cell sarcoma (1), lymphoma (1), rhabdomyosarcoma (1), and malignant giant cell tumor (1). All diagnoses were determined based on histologic findings. Six patients (19.4%) had pathologic fractures. Three of them had undergone unplanned surgeries in other institutes. The current study was approved by the Ethical Committee of the General Hospital of Jinan Military Commanding Region and every patient or parent provided written informed consent. The methods described were performed in line with relevant guidelines and regulations. All operations were performed by the same team of surgeons with adequate clinical experience in surgical oncology. Inclusion criteria for the present study were as follows: (i) primary bone malignancies and metastatic diseases of the extremities determined by histologic findings; (ii) diaphyseal tumors at least 5 cm from the lesion center to either epiphyses; (iii) LSS being performed with use of the devitalized tumor‐bearing bone and other reconstruction constructs; and (iv) adequate outcome measures including functionality, complications, and revision surgeries being recorded with a follow up of at least 12 months. Exclusion criteria were as follows: (i) benign and borderline tumors determined by histologic examination; (ii) tumors arising from the metaphyseal locations and the epiphyses, and those located in the axial sites; (iii) tumors requiring amputation or no reconstruction construct being used; and (iv) lack of outcome measures with the follow‐up duration less than 12 months. The paper has been approved by the Ethics Committee of the General Hospital of Jinan Military Commanding Region, and all patients provided written informed consent.

Preoperative Evaluation of Tumor Bone Quality

The MSS includes pain, location, tumor lesion, localized erosion, and longitudinal destruction (Table 1). In T1‐weighted magnetic resonance images, the ratio of tumor longitudinal dimension to the total shaft length reflects longitudinal destruction. The total score measures 15; higher values indicate poorer skeletal quality of tumor bones.
Table 1

Modified scoring system (MSS) indicating quality of tumor bones

SubjectValues
Location
Upper limb1
Lower limb2
Peritrochanter3
Lesion
Osteolytic1
Mixed2
Osteogenic3
Pain*
Light1
Moderate2
Severe3
Cross‐sectional extension
<1/3 circumference1
1/3–2/3 circumference2
>2/3 circumference3
Longitudinal extension
<1/3 shaft length1
1/3–2/3 shaft length2
>2/3 shaft length3

Severity of pain is determined by visual analog scale (VAS); 0–3 denotes light pain, 4–6 moderate, 7–10 severe.

Cross‐sectional extension is demonstrated through T1‐weighed axial scan by ratio of tumor extension to circumference of shaft.

Longitudinal extension is measured through T1‐weighted sagittal scan by the ratio of tumor extension to total length of shaft. Total score measures 15; higher values indicate inferior bone quality.

Modified scoring system (MSS) indicating quality of tumor bones Severity of pain is determined by visual analog scale (VAS); 0–3 denotes light pain, 4–6 moderate, 7–10 severe. Cross‐sectional extension is demonstrated through T1‐weighed axial scan by ratio of tumor extension to circumference of shaft. Longitudinal extension is measured through T1‐weighted sagittal scan by the ratio of tumor extension to total length of shaft. Total score measures 15; higher values indicate inferior bone quality.

Resection of the Tumor

All the operations were performed by a senior orthopaedic surgeon. The patient was placed in a supine position on the operating table. The skin incision, including an elliptical removal of the biopsy puncture point, was marked. After prepping and draping, the skin and superficial layer were incised, followed by wide resection of the tumor as per standards described by Enneking20. The tumor was excised with a soft tissue cuff and osteotomy was performed at least 2 cm from the end of the lesion, as indicated by the preoperative sagittal T1‐weighted MRI. Cancellous bone from the adjacent intramedullary canal was curetted and sent for frozen section to confirm a negative margin.

Reconstructive Procedures

A wide variety of techniques were performed to reconstruct the bone defect. All cases with metastases underwent endoprosthetic reconstruction due to compromised prognosis. Tumors invading an extensive range of the shaft also required prosthetic replacement. Those cases exhibiting good prognosis and showing favorable bone stock underwent biologic reconstructions. The procedures included DBR (20), segmental prosthetic replacement (4, metastases), non‐vascularized fibula autografting (2, radius), total femur replacement (2), segmental allografting (1, femur), and arthroplasty (1). Except for 1 patient exhibiting a distal radius tumor, all biological reconstructions were joint‐sparing. For DBR, two techniques were used to devitalize the tumor bone, including soaking the resected bone in ethanol (18) and in‐situ microwave ablation (2) (Fig. 1)12, 14. The former intervention comprised tumor excision, bone denuding, tumor curettage, drilling and preparation for internal fixation, soaking in 95% ethanol (30 min), and replantation14. Microwave ablation offers in vivo devitalization, with core temperatures being 108°C (30 min) and that of normal tissue ≤40°C, followed by tumor curettage and fixation12. We also used polymethylmethacrylate (PMMA) cement and bone grafting accordingly for structural augmentation and facilitation of osteosynthesis. Internal fixation for devitalized grafts included the plate (11) and the nail (9). A modular segmental prosthesis was used to fill the bone defect in the diaphysis. The two pegs of the prosthesis were inserted into the proximal and distal intramedullary canals and were fixed with the use of PMMA cement. For tumors with a wide range of erosion, total femur replacement and arthroplasty were performed. The fibula autograft was used for the distal radius with fixation of a plate. The segmental allograft was used to fill the diaphyseal defect, with fixation using a plate.
Figure 1

Flowchart of the surgical procedures. (A–D) The in‐situ microwave ablation procedures. After inactivation the tumor is thoroughly curetted, followed by structural and cancellous grafting. (E–H) The tumor bone is harvested and soaked in 95% alcohol. After inactivation the graft is re‐implanted to reconstruct the bone defect. (I–K) The tumor bone is replaced by the allograft. (L) The endoprosthesis is used to fill the bone defect.

Flowchart of the surgical procedures. (A–D) The in‐situ microwave ablation procedures. After inactivation the tumor is thoroughly curetted, followed by structural and cancellous grafting. (E–H) The tumor bone is harvested and soaked in 95% alcohol. After inactivation the graft is re‐implanted to reconstruct the bone defect. (I–K) The tumor bone is replaced by the allograft. (L) The endoprosthesis is used to fill the bone defect.

Follow up and Outcome Evaluation

For patients having biological reconstructions, operated limbs were positioned in braces and functional exercises started when wounds healed. Partial weight‐bearing ambulation was not allowed until imaging evidence and physical examination demonstrated bony union. Outpatient visits were conducted once every 3 months for the first 2 years, every 4 months in the third year, every 6 months in the fourth to fifth year, and annually afterwards. Outcome measures included the following: (i) physical examination was conducted by a clinician in the surgery team, and the gait, appearance, muscle strength, range of motion of the joints, and limb length were recorded; (ii) pulmonary CT was performed to detect metastasis; (iii) and imaging of the surgical site was performed to reveal bone healing, local complications, and recurrences. The limb function was evaluated by a clinician in the surgery team with use of the musculoskeletal tumor society (MSTS) scale. The system assigns values of 0–5 for six categories: pain, overall function, acceptance, braces, and walking and gait in lower extremities (hand positioning, dexterity, and lifting ability in upper extremities)21.

Statistical Analysis

We applied SPSS software 13.0 (SPSS, Chicago, IL, USA) for statistical analyses. Fisher's exact test was used for categorical variables, whereas analysis of variance (ANOVA) was used for continuous variables. We utilized the receiver operating characteristic curve (ROC) to exploit the efficacy of MSS. Binary logistic regression revealed the relative chance of fractures for MSS and identified the cutoff score. All values were presented as mean ± SD; P‐values < 0.05 were considered significant.

Results

General Results

At the end of the follow up, 1 case was lost and all primary tumors were rated as stage IIB according to the Ennecking surgical staging system18. The mean follow‐up duration was 61.0 ± 49.9 months (range, 12–156 months). There were 7 deaths, 9 cases of metastasis, and 4 cases of recurrences (3 located in periphery soft tissue following DBR, with 1 in bone adjacent to endoprosthesis). One case underwent amputation for recurrence following endoprosthetic replacement. Among patients with osteosarcoma (13, 44.8%), all cases had neo‐adjuvant chemotherapy and postoperative chemotherapy, as described in the literature18. Recurrence occurred in 1 subject (7.7%), metastasis in 2 (15.4%), and death in 2 (15.4%). Among 4 cases with metastases (13.8%), no recurrence occurred, while death occurred in 3 subjects (75.0%). One recurrence occurred in patients with Ewing's sarcoma (1/3, 33.3%), metastasis occurred in 2 patients (66.7%) and death in 2 patients (66.7%), respectively. All cases had neo‐adjuvant chemotherapy and chemotherapy as described in the literature18. There was no recurrence, metastasis, and death in subjects with chondrosarcoma (3). One case with malignant fibrohistiocytoma (50%) had recurrence and 1 had metastasis (50%), while no death occurred. One subject with Langerhans cell sarcoma had recurrence.

Clinical Outcomes

The DBR procedures related to lower MSS (8.9 ± 2.0 vs, 11.6 ± 1.0, P < 0.01, Fig. 2, Table 2). In the DBR group, patients had equivalent MSTS with other cases (80.4 ± 23.0% vs 76.5 ± 23.0%, P = 0.67, ANOVA) at equivalent follow up (60.1 ± 46.5 vs 63.2 ± 58.0, P = 0.88, ANOVA). Nailing correlated to higher MSS than plating (10.3 ± 0.9 vs 7.9 ± 2.1, P = 0.01, ANOVA, Table 3). This technique was associated with more primary nonunion (44.4% vs 9.1%, P = 0.02, ANOVA) and a tendency towards more frequent fractures (37.5% vs 9.1%, Fig. 3).
Figure 2

Tibial osteosarcoma (modified score system, MSS = 6) treated with devitalized bone replantation (DBR). A 14‐year old male patient presented with osteosarcoma in his left tibia. (A, B) Preoperative X‐ray films showing an osteogenic lesion. (C) Re‐implanted devitalized graft (ethanol sterilization) stabilized using a plate. (D, E) Diaphyseal union occurred 12 months after the procedure. (E, F) He had well preserved limb function 24 months after the operation.

Table 2

Analysis of factors associated with devitalized bone replantation (DBR)

VariableDBROther procedures P‐value
Age (years)27.5 ± 20.249.8 ± 27.40.02
Male (n, %)10, 52.67, 70.00.45*
Mirels’ score7.8 ± 2.010.2 ± 1.0<0.01
Modified score8.9 ± 2.011.6 ± 1.0<0.01
Operative time (min)184.5 ± 35.2159.5 ± 52.10.14
Blood loss (mL)600.0 ± 498.6735.0 ± 625.40.50
Blood transfusion (n, %)10, 66.75, 33.30.89*
Infection (n, %)1, 5.31, 10.0>0.99*
Complication (n, %)5, 26.31, 10.00.58*
Recurrence (n, %)2, 10.52, 20.00.59*
Metastases (n, %)5, 26.34, 40.00.68*
Death (n, %)5, 26.32, 20.00.54*
MSTS (%)80.4 ± 23.076.5 ± 23.00.67
Follow‐up (months)60.1 ± 46.563.2 ± 58.00.88

Denotes Fisher's exact test.

Denotes analysis of variance.

Table 3

Analysis of factors associated with fixation construct in devitalized bone replantation

VariableNailingPlating P‐value
Age (years)19.9 ± 8.733.1 ± 24.50.17
Male (n, %)5, 62.55, 45.50.65*
Mirels’ score9.1 ± 1.06.8 ± 1.90.01
Modified score10.3 ± 0.97.9 ± 2.10.01
Operative time (min)180.0 ± 29.4187.7 ± 39.90.65
Blood loss (mL)687.5 ± 543.6536.4 ± 338.40.47
Blood transfusion (n, %)6, 75.04, 36.40.17*
Infection (n, %)0, 01, 9.1>0.99*
Fracture (n, %)3, 37.51, 9.10.26*
Recurrence (n, %)2, 25.00, 00.16*
Metastases (n, %)4, 50.01, 9.10.11*
Death (n, %)4, 50.01, 9.10.11*
MSTS (%)82.1 ± 9.986.7 ± 13.80.44
Follow‐up (months)62.0 ± 52.358.7 ± 44.40.89

Denotes Fisher's exact test.

Denotes analysis of variance.

Figure 3

Diaphyseal lymphoma (modified score system, MSS = 10) treated with devitalized bone replantation (DBR). A 23‐year old male patient presented with lymphoma in his left femoral diaphysis. (A, B) Preoperative X‐ray films demonstrating a mixed lesion. (C, D) The resected specimen before and after soaking in ethanol intraoperatively with the joint being spared; (E, F) Postoperative bending and breakage of intramedullary nail while bony union was not detected at the diaphyseal site at 8 months. (G, H) The patient had revision surgery with a bracing fixator. (I) Nonunion and fracture of the graft at 36 months; he received bone grafting and plating and recovered.

Tibial osteosarcoma (modified score system, MSS = 6) treated with devitalized bone replantation (DBR). A 14‐year old male patient presented with osteosarcoma in his left tibia. (A, B) Preoperative X‐ray films showing an osteogenic lesion. (C) Re‐implanted devitalized graft (ethanol sterilization) stabilized using a plate. (D, E) Diaphyseal union occurred 12 months after the procedure. (E, F) He had well preserved limb function 24 months after the operation. Analysis of factors associated with devitalized bone replantation (DBR) Denotes Fisher's exact test. Denotes analysis of variance. Analysis of factors associated with fixation construct in devitalized bone replantation Denotes Fisher's exact test. Denotes analysis of variance. Diaphyseal lymphoma (modified score system, MSS = 10) treated with devitalized bone replantation (DBR). A 23‐year old male patient presented with lymphoma in his left femoral diaphysis. (A, B) Preoperative X‐ray films demonstrating a mixed lesion. (C, D) The resected specimen before and after soaking in ethanol intraoperatively with the joint being spared; (E, F) Postoperative bending and breakage of intramedullary nail while bony union was not detected at the diaphyseal site at 8 months. (G, H) The patient had revision surgery with a bracing fixator. (I) Nonunion and fracture of the graft at 36 months; he received bone grafting and plating and recovered. In the DBR group, fractures occurred in 4 cases (21.1%) exhibiting higher preoperative MSS (11.0 ± 1.2 vs 8.3 ± 1.8, P = 0.01, ANOVA). ROC revealed that MSS was powerful in predicting fractures (P = 0.02) and its area under the curve outweighed that of the previous system (0.90 vs 0.86), indicating that MSS may yield superior performance in diaphyseal malignancies (Fig. 4). Binary logistic regression demonstrated the MSS of 10 suggested 22.7% probability of fractures, with the false positive rate being 6.7%, while score of 11 indicated likelihood of 62.1%, with the false positive rate being 0; 10 was also the point from which fractures occurred (Table 4). Therefore, we considered 10 as the cutoff value (Fig. 5).
Figure 4

Validity of the modified scoring system (modified score system, MSS) in predicting reconstructive failures of devitalized autografts. The receiver operating characteristic curve (ROC) demonstrates the feasibility of Mirels’ score (dotted line) and MSS (solid line) in predicting reconstructive failures of devitalized autografts. MSS was effective (P = 0.02) and exhibited superior performance with regard to the area under the curve (0.90 vs 0.86).

Table 4

Modified scores and relevant chance of fractures in devitalized grafts

SubjectModified scores
689101112
Fracture000202
Non‐fracture514400
True positive rate (%)10010010050.050.00.0
False positive rate (%)66.760.033.36.70.00.0
Probability of fracture (%)0.00.15.022.762.190.1

Binary regression analysis reveals the relevant likelihood of fracture for each score. Fracture started from a score of 10. It is associated with a 22.7% chance of fracture and a 6.7% false positive rate. Higher values show a sharp increase in fracture incidence.

Figure 5

Relationship between the modified scoring system (MSS) and the probability of fractures of devitalized autografts. Relevant chance of fractures for each MSS value is demonstrated in devitalized autografts. Fractures occurring from MSS 10 suggests 22.7% chance of fractures. Higher MSS values implied dramatically increased risk of fractures.

Validity of the modified scoring system (modified score system, MSS) in predicting reconstructive failures of devitalized autografts. The receiver operating characteristic curve (ROC) demonstrates the feasibility of Mirels’ score (dotted line) and MSS (solid line) in predicting reconstructive failures of devitalized autografts. MSS was effective (P = 0.02) and exhibited superior performance with regard to the area under the curve (0.90 vs 0.86). Modified scores and relevant chance of fractures in devitalized grafts Binary regression analysis reveals the relevant likelihood of fracture for each score. Fracture started from a score of 10. It is associated with a 22.7% chance of fracture and a 6.7% false positive rate. Higher values show a sharp increase in fracture incidence. Relationship between the modified scoring system (MSS) and the probability of fractures of devitalized autografts. Relevant chance of fractures for each MSS value is demonstrated in devitalized autografts. Fractures occurring from MSS 10 suggests 22.7% chance of fractures. Higher MSS values implied dramatically increased risk of fractures.

Complication Evaluations

Infection occurred in 2 patients, 1 having total femur replacement which recovered after debridement and vacuum drainage; the other undergoing DBR had fixation removal and PMMA spacer implantation. In the DBR group, 4 patients had fractures (1 at 12 months after microwave ablation; 3 at 6, 8, and 24 months after ethanol devitalization). Because 1 subject exhibited infection, the graft was replaced with a PMMA spacer; the other 3 cases had bone grafting and internal fixation. Six patients had primary nonunion (1 after allografting and 5 following DBR). Four of them underwent bone grafting and internal fixation and union occurred in all. One had obvious limb discrepancy and knee ankylosis after DBR. Distraction osteogenesis and joint lysis were performed at 7 and 9 years. All patients exhibiting pathologic fractures underwent endoprosthetic reconstruction (Fig. 6).
Figure 6

Femur metastasis (modified score system, MSS = 12) treated with intercalary segmental endoprosthesis. A 78‐year old male patient had metastases in his left femur, (A, B) Preoperative radiographs demonstrating an osteolytic lesion located in the diaphysis. (C) Intraoperative fixation of a modular segmental endoprosthesis after wide resection of the tumor. (D, E) Postoperative radiographs of the implant. (F–H) The patient's limb function was well preserved at 12 months postoperatively.

Femur metastasis (modified score system, MSS = 12) treated with intercalary segmental endoprosthesis. A 78‐year old male patient had metastases in his left femur, (A, B) Preoperative radiographs demonstrating an osteolytic lesion located in the diaphysis. (C) Intraoperative fixation of a modular segmental endoprosthesis after wide resection of the tumor. (D, E) Postoperative radiographs of the implant. (F–H) The patient's limb function was well preserved at 12 months postoperatively.

Discussion

Efficacy of Devitalized Bone Replantation for Diaphyseal Malignancies

To date, there is no well‐established procedure for diaphyseal malignancies due to their rarity. Endoprosthetic reconstruction has been advocated because it offers instant stability and fast functional restoration8. However, prolonged life expectancies of patients result in increased revision risk (70%) of this procedure22, 23. Henderson et al. found that implant failures occurred in 25% of prostheses and reoperations can present a tremendous challenge to surgeons24, 25. Bone grafting is also a valuable procedure, but allografting requires a bone bank. Disease transmission, immunologic rejection, and nonunion (43%) are also issues of concern. Autografts may provide effective alternatives, but they are not suitable for large defects and exhibit high complication rates in diaphyses (60%)3, 4, 5. Although DBR requires a prolonged bone healing process (metaphyses, ≥7 months; diaphyses, ≥11 months)11, 13, 26, this procedure still provides the following benefits: (i) long‐term use of the graft; (ii) lower revision difficulty; (iii) perfect anatomic fit; and (iv) potential tumor‐specific immunologic activation26, 27. Whether DBR could completely eradicate tumor cells has been questioned in previous literature; however, laboratory and clinical research have validated the efficacy of the procedures used in the current study12, 14, 28, 29, 30. We also found no difference in oncologic outcomes between DBR and other procedures (Table 2). Recurrences occurred in soft tissues but not the grafts or recipient‐graft junctions; this is consistent with previous reports14, 26. Diaphyseal tumors enable surgeons to preserve the joint when performing biological reconstruction, so limb function is acceptable (77%)31. In the DBR group, patients had equivalent MSTS to other cases (80.4% ± 23.0% vs 76.5% ± 23.0%, P = 0.67, ANOVA). High complication rates following DBR (33%) were reported in the literature13. In the present study, we found that the complication rate was acceptable and comparable with that of other procedures (26.3% vs 10.0%, P = 0.58, ANOVA). Our findings (although underpowered by restricted sample size and study limitations) suggest that DBR is safe and efficacious as a treatment of diaphyseal malignancies.

Efficacy of Modified Scoring System in Predicting the Likelihood of Reconstructive Failure of Devitalized Bone Replantation

The quality of sterilized autografts is compromised by tumor invasion and devitalization. Moreover, diaphyseal locations are prone to fractures (46%) and delayed union (>11 months). Therefore, treatment of diaphyseal malignancies using DBR may theoretically be susceptible to reconstructive failures, and the bony quality of tumor bones needs to be scrutinized2. Some authors argue that only lesions exhibiting osteoblastic changes are candidates for DBR; however, lytic and mixed tumors do not necessarily have catastrophic impacts on mechanical strengths of the tumor grafts. More indices such as lesion number, tumor size, and site should be taken into consideration13. The system proposed by Mirels facilitates treatment of diaphyseal metastases, but it does not include longitudinal tumor occupancy and may not precisely indicate the mechanical strength of diaphyseal grafts2, 19. The current study demonstrates that MSS may yield favorable performance in predicting reconstructive failures of replanted tumor‐bearing autografts; cases exhibiting MSS ≥10 are exposed to ≥22.7% likelihood of fractures, although several procedures including bone grafting and cement may augment the rigidity of devitalized grafts. Skeletal quality of tumor bones remains a key factor. If it is severely disrupted, procedures other than DBR may be advisable26. This is the first study looking at the correlation between quantitative assessment of tumor bone quality and outcomes of DBR in diaphyses, MSS may provide insights into surgical selection for diaphyseal malignancies, and further long‐term studies of larger sample size are warranted to verify the potency of MSS.

Optimal Fixation Construct for Devitalized Autografts

Intramedullary nails and plates are 2 main fixators used in DBR; however, the optimal fixation construct remains to be elucidated. Nails are placed coaxially with the shaft, and biomechanical research suggests that the procedure exhibits superior axial and bending stiffness, whereas plating allows for anatomic reduction and has greater torsional tolerance32, 33, 34, 35. Several meta‐analyses have reported inconsistent findings for outcomes of the two procedures. Plating correlates with reduced risk of malalignment (8.7% vs 24.9%) and fewer shoulder problems, whereas it had equivalent performance with nailing in terms of bony union and wound complications32, 33, 34, 35. In femur shafts, due to the off‐axis loading, plating is theoretically prone to bending or breakage, whereas nailing is mechanically advantageous and may result in longer fatigue life35. Unfortunately, reports looking at fixation constructs for devitalized grafts are lacking. We infer that internal fixation in DBR may be special, because devitalized grafts have inferior bony quality. The ability of osteointegration is compromised, and this may and simulate osteoporotic bones with poor blood supply. Therefore, nailing may predispose to loss of fixation as the nail can toggle in the wide cavity, such as metaphyseal fragments and locations with skeletal defects, resulting in cut‐out of locking screws easier than plating36. Although it has been shown that adding the fixed‐angle property to interlocking screws leads to longer fatigue life of nails, the torsional stability is still inferior to plating35. There is also a potential risk of tumor contamination into the healthy medullary cavity as the nail is placed1, 37. This study shows that nailing correlates to more nonunions and a tendency towards more reconstructive failures. Although the evidence level was underpowered by the sample size, our findings still indicate that fixation constructs may exert impacts on outcomes of DBR. Combined use of plates and nails may offer a satisfactory solution. Biomechanical studies show that usage of both modalities yields more axial and torsional stability with longer fatigue life; this has also been verified in clinical studies38, 39.

Limitations of the Study

This study is subject to the limitations of a single‐center study. Due to the rarity of diaphyseal malignancies, the sample size is restricted. There was heterogeneity with regard to diagnoses, tumor locations, and treatment modalities.

Conclusions

This preliminary study suggests that MSS may be effective in predicting the likelihood of fractures of devitalized autografts. MSS ≥ 10 may contraindicate DBR, and in such situations other procedures are advisable. Further studies are warranted to verify the strength of MSS.
  39 in total

1.  Case report: Reconstruction of an intercalary defect with bone transport after resection of Ewing's sarcoma.

Authors:  John P Dormans; Onder Ofluoglu; Bulent Erol; Leslie Moroz; Richard S Davidson
Journal:  Clin Orthop Relat Res       Date:  2005-05       Impact factor: 4.176

Review 2.  Methods of biological reconstruction for bone sarcoma: indications and limits.

Authors:  Pierre Kunz; Ludger Bernd
Journal:  Recent Results Cancer Res       Date:  2009

3.  Does the second-generation intercalary humeral spacer improve on the first?

Authors:  Timothy A Damron; Taninnit Leerapun; Ronald R Hugate; Thomas C Shives; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

4.  Epidiaphyseal versus other intercalary allografts for tumors of the lower limb.

Authors:  R L M Deijkers; R M Bloem; H M Kroon; J B Van Lent; R Brand; A H M Taminiau
Journal:  Clin Orthop Relat Res       Date:  2005-10       Impact factor: 4.176

5.  Minimally invasive fracture stabilization of distal femoral fractures with the LISS: a prospective multicenter study. Results of a clinical study with special emphasis on difficult cases.

Authors:  M Schütz; M Müller; C Krettek; D Höntzsch; P Regazzoni; R Ganz; N Haas
Journal:  Injury       Date:  2001-12       Impact factor: 2.586

6.  Vascularized free fibula transfer for oncologic reconstruction of the humerus.

Authors:  Peter S Rose; Alexander Y Shin; Allen T Bishop; Steven L Moran; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

7.  Comparison of the LISS and a retrograde-inserted supracondylar intramedullary nail for fixation of a periprosthetic distal femur fracture proximal to a total knee arthroplasty.

Authors:  Matthew R Bong; Kenneth A Egol; Kenneth J Koval; Frederick J Kummer; Edward T Su; Kazuho Iesaka; Jordi Bayer; Paul E Di Cesare
Journal:  J Arthroplasty       Date:  2002-10       Impact factor: 4.757

8.  Pedicle frozen autograft reconstruction in malignant bone tumors.

Authors:  Hiroyuki Tsuchiya; Hideji Nishida; Phutsapong Srisawat; Toshiharu Shirai; Katsuhiro Hayashi; Akihiko Takeuchi; Norio Yamamoto; Katsuro Tomita
Journal:  J Orthop Sci       Date:  2010-06-18       Impact factor: 1.601

9.  Prognostic effect of diaphyseal location in osteosarcoma: a cohort case-control study at a single institute.

Authors:  Chang-Bae Kong; Min Suk Kim; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jun Ah Lee; Ji Young Yoo; So Hak Chung; Dae-Geun Jeon
Journal:  Ann Surg Oncol       Date:  2009-08-21       Impact factor: 5.344

10.  Intercalary femur and tibia segmental allografts provide an acceptable alternative in reconstructing tumor resections.

Authors:  D Luis Muscolo; Miguel A Ayerza; Luis Aponte-Tinao; Maximiliano Ranalletta; Eduardo Abalo
Journal:  Clin Orthop Relat Res       Date:  2004-09       Impact factor: 4.176

View more
  2 in total

1.  Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities.

Authors:  Kai Zheng; Xiuchun Yu; Yongcheng Hu; Yingze Zhang; Zhen Wang; Sujia Wu; Jingnan Shen; Zhaoming Ye; Chongqi Tu; Yu Zhang; Xing Wei; Yong Hu; Xuquan Wang; Jiazhen Li; Hong Duan; Yuxian Wu; Ming Xu; Zhenchao Yuan; Yongzhong Wei; Bingyao Chen
Journal:  Orthop Surg       Date:  2020-08-09       Impact factor: 2.071

2.  Development and Validation of a Novel Scoring System for Severity of Plantar Fasciitis.

Authors:  Meng-Chen Yin; Yin-Jie Yan; Zheng-Yi Tong; Chong-Qin Xu; Jiao-Jiao Qiao; Xiao-Ning Zhou; Jie Ye; Wen Mo
Journal:  Orthop Surg       Date:  2020-10-28       Impact factor: 2.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.